Cite
APA Citation
Le Gars, M., Sadoff, J., Jongeneelen, M., Heerwegh, D., Shukarev, G., Truyers, C., de Groot, A. M., Scheper, G., Hendriks, J., Brandenburg, B., Struyf, F., Van Hoof, J., Douoguih, M., & Schuitemaker, H. (n.d.). lB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials. Open forum infectious diseases, 8, S804–S805. http://access.bl.uk/ark:/81055/vdc_100150542774.0x000021